Clinical Chemistry and Laboratory Medicine (CCLM)

Titel Veröffentlichungsdatum Sprache Zitate
Hyperuricemia as risk factor for coronary heart disease incidence and mortality in the general population: a systematic review and meta-analysis2016/01/01111
Reticulated platelets: analytical aspects and clinical utility2014/01/01111
Biomarkers for prostate cancer: prostate-specific antigen and beyond2019/11/12English111
Quantification of glyoxal, methylglyoxal and 3-deoxyglucosone in blood and plasma by ultra performance liquid chromatography tandem mass spectrometry: evaluation of blood specimen2014/01/01111
Evaluation of [−2] proPSA and Prostate Health Index (phi) for the detection of prostate cancer: a systematic review and meta-analysis2012/11/15English108
Telomere biology and age-related diseases2018/07/26107
TaqMan Systems for Genotyping of Disease-Related Polymorphisms Present in the Gene Encoding Apolipoprotein E2002/01/02105
Why are clinical practice guidelines not followed?2015/12/09English104
A checklist for critical appraisal of studies of biological variation2015/01/01102
Aberrant glycosylation and cancer biomarker discovery: a promising and thorny journey2018/08/23English102
Reference Ranges for Serum Concentrations of Lutropin (LH), Follitropin (FSH), Estradiol (E2), Prolactin, Progesterone, Sex Hormone-Binding Globulin (SHBG), Dehydroepiandrosterone Sulfate (DHEAS), Cortisol and Ferritin in Neonates, Children and Young Adults2002/01/02100
Trace elements and bone health2013/03/18English100
Characterisation of a highly sensitive troponin I assay and its application to a cardio-healthy population2012/05/0199
Routine use of the Ion Torrent AmpliSeq™ Cancer Hotspot Panel for identification of clinically actionable somatic mutations2014/01/0199
High-dose biotin therapy leading to false biochemical endocrine profiles: validation of a simple method to overcome biotin interference2017/06/0198
Neutrophil gelatinase-associated lipocalin (NGAL) as biomarker of acute kidney injury: a review of the laboratory characteristics and clinical evidences2012/09/0196
The role of red blood cell distribution width in cardiovascular and thrombotic disorders2012/01/0194
Practical recommendations for managing hemolyzed samples in clinical chemistry testing2018/01/26English92
First fully automated immunoassay for anti-Müllerian hormone2014/01/0190
Current and future use of “dried blood spot” analyses in clinical chemistry2013/06/01English89
Development, evaluation, and validation of machine learning models for COVID-19 detection based on routine blood tests2020/10/21English87
Assessment of immune response to SARS-CoV-2 with fully automated MAGLUMI 2019-nCoV IgG and IgM chemiluminescence immunoassays2020/04/16English87
High sensitivity cardiac troponin assays in the clinical laboratories2015/01/0186
Validation of a Kinetic Model for the Reactions in RIA2002/01/0286
Evaluation of cannabinoids concentration and stability in standardized preparations of cannabis tea and cannabis oil by ultra-high performance liquid chromatography tandem mass spectrometry2017/01/0185
The theory of reference values: an unfinished symphony2012/11/24English85
Monitoring multiple myeloma patients treated with daratumumab: teasing out monoclonal antibody interference2016/01/0185
Copeptin (CTproAVP), a new tool for understanding the role of vasopressin in pathophysiology2014/01/0185
Role of leptin in female reproduction2015/01/0184
microRNAs in cardiovascular disease – clinical application2017/01/0184